Home
Scholarly Works
Clinical outcomes associated with azacitidine...
Conference

Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naive, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.

Authors

Hasegawa K; Wei AH; Garcia-Manero G; Daver NG; Rajakumaraswamy N; Iqbal S; Chan RJ; Hu H; Tse P; Yan J

Volume

40

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

June 1, 2022

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

ELECTR NETWORK

Conference start date

June 3, 2022

Conference end date

June 7, 2022

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team